Company profile

Perseus Proteomics Inc.

EDINET
E35510
Securities
4882
Industry
Pharmaceutical
Industry Peer Ranking
View Company Rankings
Latest annual securities report
2026-06-30 Amended Annual Securities Report PDF HTML
Latest financial report
2026-11-13 Semiannual Securities Report PDF HTML
Latest filing
—

Industry position

Pharmaceutical

View details
Profitability Weak Current Bottom 12% 5-year trend Deteriorating
Financial strength Average Based on Equity ratio Current Top 46% 5-year trend Deteriorating
Growth Strong Current Top 16% 5-year trend Improving
Cash generation Weak Current Bottom 10% 5-year trend Broadly stable

Latest half-year results

H1 FY2027

2026/04/01 - 2026/09/30

Standalone · Japanese GAAP · Cumulative YTD

For H1 FY2027, revenue was ¥52.63 million, down 13.7% year over year. Operating income was -¥411.09 million, down 2.8% year over year. Net income was -¥399.21 million, down 5.2% year over year.

Revenue ¥52.63M down 13.7% year over year
Operating income -¥411.09M down 2.8% year over year
Net income -¥399.21M down 5.2% year over year
Operating cash flow -¥292.38M
Free cash flow -¥293.52M
Total assets ¥1.51B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Standalone · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2026

Standalone Japanese GAAP

Revenue reached ¥135.51 million, up 12.6% year over year. Operating income was -¥744.96 million. Operating margin was -549.8%. Net income was -¥718.11 million. ROE was -54.2%; equity ratio was 70.1%; free cash flow was -¥663.4 million.

Revenue ¥135.51M up 12.6% year over year
Operating income -¥744.96M
Net income -¥718.11M
Total assets¥1.62B
Total equity—
Operating cash flow-¥653.33M
Free cash flow-¥663.4M

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Weak

Operating margin Bottom 93% / ROE Bottom 90%

Financial strength Average
Based on Equity ratio

Equity ratio Top 48%

Growth Strong

Revenue growth Top 26% / 3-year revenue CAGR Top 12%

Cash generation Weak

Operating cash flow margin Bottom 94% / Free cash flow margin Bottom 94%

Profitability Industry position history Deteriorating
2026 Bottom 12% 2025 Bottom 16% 2024 Bottom 17% 2023 Bottom 20% 2022 Bottom 22%
Financial strength Industry position history Deteriorating
2026 Top 46% 2025 Top 36% 2024 Top 38% 2023 Top 10% 2022 Top 0%
Growth Industry position history Improving
2026 Top 16% 2025 Top 13% 2024 Top 26% 2023 Top 6% 2022 Bottom 45%
Cash generation Industry position history Broadly stable
2026 Bottom 10% 2025 Bottom 16% 2024 Bottom 12% 2023 Bottom 20% 2022 Bottom 16%
Profitability Operating margin -549.8% Industry median 6.9% Bottom 93% Comparison sample 42
Profitability ROE -54.2% Industry median 3.8% Bottom 90% Comparison sample 48
Financial strength Equity ratio 70.1% Industry median 68.3% Top 48% Comparison sample 50
Growth Revenue growth +12.6% Industry median +4.2% Top 26% Comparison sample 31
Growth 3-year revenue CAGR +12.9% Industry median +5.2% Top 12% Comparison sample 26
Cash generation Operating cash flow margin -482.1% Industry median 7.4% Bottom 94% Comparison sample 43
Cash generation Free cash flow margin -489.6% Industry median -0.6% Bottom 94% Comparison sample 43

Annual financial data

Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Implied Share Price Implied Market Capitalization Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2026 Standalone Japanese GAAP 135507000 -744955000 -678921000 -716181000 -718108000 1623541000 405771000 1217770000 1137388000 1217770000 -653334000 -10062000 497333000 -663396000 1515346000 -48.17 66.91 1.69996E+7 0.7500703709 0.7006 -0.5419323094 -0.4423097415 -5.4975388725 -5.0102282539 -4.8214040603 -4.8956585269 0.1257071651 0.1818543338 0.2063069353 -0.1073741077 -0.1498429914 0.0919421531 0.8661202549 -0.4614000071 0.1651636838 -0.091476155 0.2403406403 0.1525543239 0.09375 0.0321457821 35 7778263
FY2025 Standalone Japanese GAAP 120375000 -826430000 -829829000 -902340000 -904800000 1818837000 386431000 1432406000 1353183000 1432406000 -719485000 -75157000 923381000 -794642000 1667921000 -63.41 91.74 1.47495E+7 0.7875395101 0.744 -0.6392652124 -0.49746074 -6.8654620976 -6.8936988577 -5.9770301142 -6.6013873313 0.1989303002 0.056347654 0.1815755175 0.0738140642 0.024358813 0.1372026315 0.5000964461 13.440689364 0.1926347307 0.0820685356 0.3231935105 0.2356740726 0.28 0.0324362003 32 7536012
FY2024 Standalone Japanese GAAP 100402000 -894729000 -879380000 -1102533000 -1104460000 1693810000 295465000 1398344000 1324205000 1398344000 -833898000 -150343000 63943000 -984241000 1541419000 -93.69 110.94 1.19364E+7 0.8255613085 0.7818 -0.5820776313 -0.6520566061 -8.9114659071 -8.7585904663 -8.3055915221 -9.8030019322 0.0658273267 -0.2751956195 -0.4043718283 -0.3400697407 -0.4165166938 -0.4778246029 0.2941278658 3198.15 -0.2662908179 -0.3695457628 -0.3998207082 0.0150517884 0.0416666667 0.124614857 25 7299252
FY2023 Standalone Japanese GAAP 94201000 -697769000 -689604000 -785072000 -786999000 2566650000 170105000 2396545000 2365134000 2396545000 -564274000 -212989000 -20000 -777263000 2444934000 -66.93 201.13 1.17594E+7 0.9337248943 0.9215 -0.3066249781 -7.407235592 -7.3205592297 -5.9901062621 -8.2511119839 0.3095840516 -0.4316612032 -0.3148170478 -0.2223521677 -0.2397119557 -0.1833563319 -5.2887976851 -1.0000075542 -0.5219263378 -0.239487852 -0.2287497705 0.0 0.1428571429 0.0206297718 24 6490446
FY2022 Standalone Japanese GAAP 71932000 -472195000 -481681000 -597096000 -599023000 3300530000 148375000 3152154000 3152154000 3152154000 -476842000 -33868000 2647548000 -510710000 3214852000 -54.47 268.05 1.17594E+7 0.9550447958 0.955 -0.282833715 -0.1814929723 -6.5644636601 -6.6963382083 -6.6290663404 -7.0998999055 0.0586486526 -0.1745251849 -0.451767492 1.9505214433 1.9086612415 -0.1277232781 -10.992917847 1.6186382339 -0.199807358 2.0065014495 0.0772488565 0.4021987981 0.1052631579 0.0095369541 21 6359256
FY2021 Standalone Japanese GAAP 67947000 -411749000 -410107000 -411289000 -413216000 1118626000 34912000 1083713000 1080673000 1083713000 -422836000 -2824000 1011040000 -425660000 1069300000 -59.03 128.86 8386400.0 0.9687893898 0.9661 -0.5265232842 -0.3693960269 -6.0598554756 -6.0356895816 -6.2230267709 -6.2645885764 -0.2076983174 0.5084783343 0.5102559645 1.0417018776 0.305144908 0.1716045761 0.304400972 19 6299181
FY2020 Standalone Japanese GAAP
FY2019 Standalone Japanese GAAP
FY2018 Standalone Japanese GAAP
FY2017 Standalone Japanese GAAP

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.